reSET® is a 12-week prescription digital therapeutic for patients with substance use disorder, who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is the first FDA-authorized treatment shown to increase abstinence and retention over the 12-week trial duration (1,2).
Get therapy on demand.
Interactive Cognitive Behavioral Therapy lessons help you learn new skills you can use in everyday situations to support your recovery (2).
Strengthen coping strategies.
Questions at the end of each lesson help you remember important ideas and practice skills to stay in treatment (2).
Earn rewards.
Use an evidence-based rewards system designed to support your recovery and treatment (2).
Track your cravings and triggers.
Record substance use, cravings, and triggers with just a tap, so you and your therapist or doctor can better understand how you’re doing (2).
If you’ve been in an outpatient treatment program before for substance use disorder, you know that recovery can be a challenging, ongoing process. Especially in between therapy sessions, when you may not be able to access a counselor or doctor but still need support.
reSET is a Prescription Digital Therapeutic—a new type of therapy prescribed by doctors designed to help with treatment. It lets you continue the work you’re doing in recovery on your smartphone or tablet, so you can build new skills and get support—anytime, anywhere.
Important Safety Information
Warnings/precautions: Do not use reSET to communicate any emergency, urgent or critical information. reSET does not include features that can send alerts or warnings to your clinician. If you have feelings or thoughts of harming yourself or others, please dial 911 or go to the nearest emergency room.
reSET is intended for patients whose primary language is English or Spanish, who have access to a compatible tablet or smartphone and are familiar with the use of smartphone applications (apps). You should be able to upload data periodically, i.e. have internet/wireless connection access.
reSET requires you to enter a user name and password prior to use. Please do not share your user name and password with others. reSET may contain and transmit protected health information and/or personally identifiable information.
reSET is not intended to be used as stand-alone therapy for substance use disorder (SUD) and does not replace care by your provider. reSET is not a substitute for your medications. You should continue to take your medications as directed by your provider.
The long-term benefit of treatment with reSET on abstinence has not been evaluated in studies lasting beyond 12 weeks (90 days) in the SUD population. The ability of reSET to prevent potential relapse after treatment discontinuation has not been studied. The safety and effectiveness of reSET has not been established in patients enrolled in opioid treatment programs.
Please see the Patient Brief Summary Instructions for reSET: https://bit.ly/2VyhMOn
1. FDA permits marketing of mobile medical application for substance use disorder. News release. Silver Spring, MD: US Food and Drug Administration. September 14, 2017. Accessed May 18, 2020. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-mobile-medical-application-substance-use-disorder
2. reSET Patient directions for use. Pear Therapeutics, Inc. 2020.
Get therapy on demand.
Interactive Cognitive Behavioral Therapy lessons help you learn new skills you can use in everyday situations to support your recovery (2).
Strengthen coping strategies.
Questions at the end of each lesson help you remember important ideas and practice skills to stay in treatment (2).
Earn rewards.
Use an evidence-based rewards system designed to support your recovery and treatment (2).
Track your cravings and triggers.
Record substance use, cravings, and triggers with just a tap, so you and your therapist or doctor can better understand how you’re doing (2).
If you’ve been in an outpatient treatment program before for substance use disorder, you know that recovery can be a challenging, ongoing process. Especially in between therapy sessions, when you may not be able to access a counselor or doctor but still need support.
reSET is a Prescription Digital Therapeutic—a new type of therapy prescribed by doctors designed to help with treatment. It lets you continue the work you’re doing in recovery on your smartphone or tablet, so you can build new skills and get support—anytime, anywhere.
Important Safety Information
Warnings/precautions: Do not use reSET to communicate any emergency, urgent or critical information. reSET does not include features that can send alerts or warnings to your clinician. If you have feelings or thoughts of harming yourself or others, please dial 911 or go to the nearest emergency room.
reSET is intended for patients whose primary language is English or Spanish, who have access to a compatible tablet or smartphone and are familiar with the use of smartphone applications (apps). You should be able to upload data periodically, i.e. have internet/wireless connection access.
reSET requires you to enter a user name and password prior to use. Please do not share your user name and password with others. reSET may contain and transmit protected health information and/or personally identifiable information.
reSET is not intended to be used as stand-alone therapy for substance use disorder (SUD) and does not replace care by your provider. reSET is not a substitute for your medications. You should continue to take your medications as directed by your provider.
The long-term benefit of treatment with reSET on abstinence has not been evaluated in studies lasting beyond 12 weeks (90 days) in the SUD population. The ability of reSET to prevent potential relapse after treatment discontinuation has not been studied. The safety and effectiveness of reSET has not been established in patients enrolled in opioid treatment programs.
Please see the Patient Brief Summary Instructions for reSET: https://bit.ly/2VyhMOn
1. FDA permits marketing of mobile medical application for substance use disorder. News release. Silver Spring, MD: US Food and Drug Administration. September 14, 2017. Accessed May 18, 2020. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-mobile-medical-application-substance-use-disorder
2. reSET Patient directions for use. Pear Therapeutics, Inc. 2020.
Show More
